Technology Development Through Pooling ARV Drug Patents: A Vision from China.
Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China.The way Chinese government can go to breakthrough the ARV drug patents are suggested as:Make more generic drugs available through compulsory licensing, impartment from other countries or building ARVs plants by partnerships between governments or generic drug companies.Do a thorough and detailed research on the patent application of ARV drugs to find out the loophole.Try patent pool to make AIDS medicines more affordable and appropriate for patients.
Liu
Li
L
Department of Infectious Disease, Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai, 201508, China.
Lu
Hongzhou
H